Hazardous Pharmaceutical Waste Disposal: Rules, Manifests, and Penalties

Hazardous pharmaceutical waste disposal rules come from a layered federal framework: the EPA enforces the Resource Conservation and Recovery Act (RCRA), with healthcare facilities and reverse distributors following a dedicated track under 40 CFR Part 266, Subpart P, and pharmaceutical manufacturers following the standard generator requirements in 40 CFR Part 262. The Drug Enforcement Administration controls destruction of scheduled substances separately, and the Department of Transportation governs shipping. Civil penalties for RCRA violations reach $124,426 per violation per day under current inflation-adjusted figures, so the compliance stakes are real.

Which Rules Apply to Your Facility

The EPA’s 2019 Hazardous Waste Pharmaceuticals Rule created Subpart P specifically for healthcare facilities and reverse distributors. Entities on that track manage hazardous waste pharmaceuticals under Subpart P instead of the standard generator, transporter, and disposal facility rules in Parts 262 through 265.¹ “Healthcare facility” is defined broadly. It covers hospitals, pharmacies, physician offices, veterinary clinics, long-term care facilities, ambulance services, and even retailers that sell over-the-counter drugs.

Very Small Quantity Generators that qualify as healthcare facilities get a partial exemption. They stay under the standard VSQG rules in §262.14 rather than the full Subpart P framework, but they must still follow the sewer prohibition and the empty-container standards. Pharmaceutical manufacturers and reverse logistics centers are not covered by Subpart P at all; they follow standard RCRA generator requirements in Part 262.¹

Generator size still matters even under Subpart P, because it drives the VSQG carve-out and sets the baseline for anyone on the standard track. The categories are defined by monthly generation:²

Very Small Quantity Generator (VSQG): 100 kilograms or less per month, or 1 kilogram or less of acutely hazardous waste; on-site accumulation capped at 1,000 kg.
Small Quantity Generator (SQG): more than 100 but less than 1,000 kilograms per month; 180-day on-site storage limit (270 days for long-haul shipments), 6,000 kg cap.
Large Quantity Generator (LQG): 1,000 kilograms or more per month, or more than 1 kilogram of acutely hazardous waste; 90-day on-site storage limit.³

Identifying Hazardous Pharmaceutical Waste

Every downstream decision — how to store, label, ship, and destroy the waste — depends on classifying it correctly. A discarded medication is a hazardous waste under RCRA if it appears on one of the EPA’s hazardous waste lists or exhibits a hazardous characteristic.⁴

Listed Wastes: The P-List and U-List

Certain pharmaceuticals appear by name on the EPA’s hazardous waste lists in 40 CFR 261.33. P-list substances are acutely hazardous, so even small amounts trigger strict handling. Nicotine sits on the P-list as P075, but the EPA carved out an exception in 2019: FDA-approved over-the-counter nicotine replacement therapies (patches, gums, lozenges) are no longer P075 waste.⁵ U-list substances are toxic or otherwise hazardous but not acutely so. Both lists apply only when the pharmaceutical is the sole active ingredient in a commercial chemical product that is discarded unused.

Characteristic Wastes

A pharmaceutical not on either list can still be hazardous if it exhibits one of four characteristics:⁶

Ignitability (D001): liquid preparations with a flash point below 140°F. Alcohol-based solutions are the common trigger, though the rule excludes solutions with less than 24% alcohol by volume and at least 50% water by weight.
Corrosivity (D002): aqueous substances with a pH at or below 2, or at or above 12.5.
Reactivity (D003): substances that are unstable, react violently with water, or can generate toxic gases in normal handling.
Toxicity: substances that leach regulated contaminants above threshold concentrations under the Toxicity Characteristic Leaching Procedure. The relevant pharmaceutical thresholds include 5.0 mg/L for lead and 0.2 mg/L for mercury.⁷

When a Container Is Considered Empty

Residues in vials and syringes create constant classification questions. Subpart P sets specific “empty” standards; once a container meets them, it and its residues are no longer regulated as hazardous waste. Stock bottles, dispensing bottles, vials, and ampules (up to 1 liter or 10,000 pills) are empty once the contents have been removed using ordinary practices for that container type. A syringe is empty once the plunger is fully depressed. An IV bag is empty once its contents have been fully administered to a patient, or if it held a non-acute hazardous waste pharmaceutical and meets the general empty-container standard in §261.7(b)(1).¹ Partially administered containers that don’t meet these standards are managed as non-creditable hazardous waste pharmaceuticals.

The Sewer Prohibition

Do not flush hazardous waste pharmaceuticals. All healthcare facilities (including VSQGs) and all reverse distributors are prohibited from discharging hazardous waste pharmaceuticals to any sewer system that passes through to a publicly owned treatment works.⁸ The ban applies regardless of generator size, with no de minimis exception. It does not extend to pharmaceutical manufacturers unless they also operate as reverse distributors. Sewering was common practice at many facilities before Subpart P took effect, and it catches smaller operations off-guard.

Storing Waste On-Site

Containers must be compatible with the chemical properties of the waste, structurally sound, and designed to prevent leaks. They stay closed except when adding or removing waste. Incompatible wastes — strong oxidizers and flammable liquids, for example — must never share a container or sit near each other without a physical barrier like a berm or dike.³ Every container must be marked with the words “Hazardous Waste” and the specific hazard (such as “Toxic” or “Flammable”). Facilities on the standard Part 262 track must also show the accumulation start date.

Storage areas must be inspected at least weekly for leaks and corrosion. If a problem is found, the waste has to be moved to a sound container or otherwise managed to prevent a release.⁹ Document every inspection. Those logs are among the first things regulators ask for.

Healthcare facilities under Subpart P follow that subpart’s container management standards rather than the satellite/central accumulation area framework in Part 262. The practical requirements — sound containers, proper labeling, segregation of incompatibles — look similar, but the regulatory pathway is different, and the empty-container standards above apply.

Authorized Disposal Methods

Incineration at a Permitted TSDF

The main destruction method for RCRA hazardous pharmaceutical waste is high-temperature incineration at a Treatment, Storage, and Disposal Facility permitted under 40 CFR Part 264. The TSDF has to be permitted for the specific waste codes you’re shipping; a facility authorized for one type of hazardous waste is not automatically authorized for others.¹⁰ Landfilling is prohibited for most RCRA hazardous wastes.

Reverse Distribution Is Not Disposal

Reverse distribution is a product-return pathway, not a disposal method. Unused, unexpired pharmaceuticals that may qualify for manufacturer credit can be sent to a reverse distributor for evaluation. Under Subpart P, the reverse distributor must inventory each incoming item within 30 days and evaluate whether it is destined for manufacturer credit or for a permitted disposal facility.¹¹ Products that are expired, partially used, contaminated, or already placed into a hazardous waste container are ineligible. Once a pharmaceutical becomes a waste, the reverse distribution pathway closes.

Controlled Substances Follow a Separate Track

DEA rules for controlled substance destruction run parallel to the EPA framework, and they apply whether or not the substance is also RCRA-hazardous. Every controlled substance must be rendered “non-retrievable,” meaning no one can recover or use it after destruction. Incineration and approved chemical deactivation are the common methods. If multiple controlled substances are mixed, the destruction method must be sufficient to render all of them non-retrievable.¹²

On-site destruction at a registrant’s location requires two employees to handle or observe the handling of the substance until it is non-retrievable, and two employees to personally witness the destruction.¹³ For off-site destruction, two employees of the transferring registrant must load and unload (or observe the loading and unloading of) the substances until the transfer is complete. The witness requirements exist to prevent diversion.

Practitioners who want to dispose of controlled substances from inventory can submit DEA Form 41 to the Special Agent in Charge in their area to request disposal assistance. The form initiates the process rather than certifying that destruction already happened.¹⁴ Alternatively, the substances can be transferred to a DEA-registered reverse distributor or destroyed on-site under the witness procedures above. The DEA requires a complete chain-of-custody record from acquisition through final destruction. Do not mix controlled substances into a general hazardous pharmaceutical waste stream without confirming the applicable DEA requirements first.

Shipping and Paperwork

Packaging and Shipping Papers

Waste must be packaged to DOT standards in 49 CFR Parts 173, 178, and 180 before it leaves the facility.¹ DOT shipping papers must include, in the required sequence, the UN identification number, the proper shipping name, the hazard class or division number, the packing group, the total quantity, and the number and type of packages. If the material qualifies as a hazardous substance, “RQ” (reportable quantity) must appear before or after the description. An emergency response telephone number and a shipper’s certification are also required.¹⁵

The Hazardous Waste Manifest

The Uniform Hazardous Waste Manifest (EPA Form 8700-22) tracks hazardous waste from generation to final disposal. Federal regulations require generators, transporters, and TSDFs to use the form for interstate and intrastate shipments alike.¹⁶ The generator is responsible for listing the correct EPA hazardous waste codes and DOT shipping names. The manifest can serve as the DOT shipping paper if it contains all the DOT-required information. Manifests can be submitted through the EPA’s e-Manifest system.¹⁷

Recordkeeping

Generators must keep signed copies of each manifest for at least three years from the date the waste was accepted by the initial transporter. The same three-year minimum applies to biennial reports and exception reports.¹⁸ Retention periods extend automatically during any unresolved enforcement action. DOT separately requires shipping paper copies for three years after the waste is accepted by the initial carrier.¹⁵ Enforcement actions can surface years after a shipment, so keeping records well past the minimum is prudent.

Training

LQG personnel who handle or manage hazardous waste must complete initial training within six months of starting the job and participate in an annual review. The program has to cover emergency procedures, contingency plan implementation, and duties specific to each employee’s position, and it must be directed by a person trained in hazardous waste management.³ Employees may not work unsupervised until they’ve completed the training. Written job descriptions, employee names, and training records must be kept at the facility.

Contingency Plans and Biennial Reports

LQGs must maintain a written contingency plan describing how personnel will respond to fires, explosions, or unplanned releases. The plan lists emergency coordinators and their 24-hour contact information, describes arrangements with local police and fire departments, inventories emergency equipment on-site, and includes an evacuation plan. A copy goes to every local emergency responder that might be called.¹⁹

LQGs that ship hazardous waste off-site during any odd-numbered year must file a Biennial Report (EPA Form 8700-13 A/B) by March 1 of the following even-numbered year, detailing types and quantities shipped.²⁰ Some states require annual reporting or additional notifications beyond the federal biennial schedule, so check with your state environmental agency.

Penalties for Getting It Wrong

RCRA civil penalties have been adjusted upward for inflation well beyond the original $25,000 statutory amount. As of the most recent adjustment effective January 8, 2025, a single RCRA violation can result in a civil penalty of up to $124,426 per day under 42 U.S.C. 6928(a)(3).²¹ The figure is per violation per day, so a facility with multiple ongoing violations can face exposure in the millions within weeks. Separate RCRA provisions carry penalties of up to $74,943 and $93,058 per violation per day, depending on the statutory subsection.

DEA violations for mishandling controlled substances can bring federal criminal penalties, including substantial fines and imprisonment. The combination of EPA civil exposure and DEA criminal exposure makes pharmaceutical waste one of the higher-risk compliance areas in healthcare operations. Facilities that invest in proper training, clear procedures, and documented waste determinations tend to avoid the kind of cascading violations that turn a labeling mistake into a six-figure enforcement action.